Evoke plc (LON:EVOK – Get Free Report)’s share price dropped 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
A number of research firms have issued reports on EVOK. Berenberg Bank decreased their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th.
Read Our Latest Analysis on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, sell-side analysts forecast that Evoke plc will post 12.7648305 EPS for the current year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Corporate insiders own 27.00% of the company’s stock.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- How to Calculate Options Profits
- MarketBeat Week in Review – 03/24 – 03/28
- Investing In Automotive Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.